Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-776P is a **pseudogene** copy of the U6 small nuclear RNA (snRNA) gene, categorized as "RNA, U6 small nuclear 776, pseudogene." Functional copies of U6 snRNA are essential components of the spliceosome, involved in pre-mRNA splicing, but pseudogenes like RNU6-776P are non-functional genetic elements that do not encode active RNA molecules or proteins[1][3][4]. Such pseudogenes are common in mammalian genomes and have no established biological function or role as therapeutic targets. Their presence reflects the evolutionary history of gene duplication and mutation, but they are not considered relevant for drug targeting, disease association, or biomarker development[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 776, pseudogene (RNU6-776P).